Conaghan PG, Bowes MA, Kingsbury SR, et al. Miv-711, a Novel Cathepsin K Inhibitor Demonstrates Evidence of Osteoarthritis Structure Modification: Results from a 6 Month Randomized Double-Blind Placebo-Controlled Phase IIA Trial. ACR 2017, abstract 14L.
Druk op zorg door dure geneesmiddelen. Maar is dat wel zo?
jun 2020 | Immuuntherapie, RA